Apogee Therapeutics, Inc.

Direct answer

Apogee Therapeutics, Inc. is publicly traded on NASDAQ under the ticker APGE.

Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and...

Can you invest in Apogee Therapeutics, Inc.?

Yes. Apogee Therapeutics, Inc. is publicly traded on NASDAQ under the ticker APGE.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Apogee Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.